
Keywords: HT; hormone therapy; HR; hazard ratio; CI; confidence interval; RCT; randomized controlled trial; RR; risk ratio; SMR; standardized mortality ratio; ESR; estrogen receptor; PR; progesterone receptor; NSCLC; non-small cell lung carcinoma; Lung cancer; Horm